Ulrike Gnad-Vogt

Corporate Officer/Principal at CUREVAC N.V.

Net worth: 103 438 $ as of 2024-03-30

Health Technology

Consumer Services

Profile

Ulrike Gnad-Vogt is currently working as the Chief Medical Officer at CureVac SE since 2011.
Additionally, she holds the position of Senior Vice President & Head-Oncology at CureVac NV since 2011.
Dr. Gnad-Vogt obtained a doctorate degree from Universität des Saarlandes.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CUREVAC N.V. 0.02%	2023-03-30	34,138 ( 0.02% )	103 438 $	2024-03-30

Ulrike Gnad-Vogt active positions

Companies	Position	Start
CUREVAC N.V.	Corporate Officer/Principal	2018-12-31
CureVac SE CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany.	Chief Tech/Sci/R&D Officer	2010-12-31

All active positions of Ulrike Gnad-Vogt

Training of Ulrike Gnad-Vogt

Universität des Saarlandes

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ulrike Gnad-Vogt's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
CUREVAC N.V.	Health Technology

Private companies	1
CureVac SE CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany.	Health Technology